Cardio-microcurrent device for chronic heart failure: first-in-human clinical study.
Dragana KosevicDominik WiedemannPetar M VukovicVelibor RisticJulia RiebandtUna RadakKersten BrandesPeter GöttelHans-Dirk DuengenElvis TahirovicTatjana KottmannHans Werner VossMarija ZdravkovićSvetozar PutnikJan D SchmittoJohannes MuellerJesus Eduardo RameMiodrag PericPublished in: ESC heart failure (2021)
Chronic application of microcurrent to the heart is feasible and safe and leads to a rapid and lasting improvement in heart function and a near normalization of heart size within days. The NYHA classification and quality of life improve just as rapidly.